Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 29, 2024	Sep. 29, 2023
Current assets:
Cash and cash equivalents	$ 709,535	$ 745,364
Restricted cash	114,821	72,602
Short-term investments	115,863	139,148
Accounts receivable, net of allowance for credit losses of $6,213 and $9,683	282,131	262,245
Contract assets, net of allowance for credit losses of $105 and $138	243,170	182,130
Inventories, net	35,797	35,623
Prepaid expenses and other current assets	50,421	50,692
Total current assets	1,551,738	1,487,804
Long-term investments	127,973	97,812
Property, plant, and equipment, net	481,492	481,581
Operating lease right-of-use assets	43,057	40,199
Intangible assets, net	152,149	167,427
Goodwill	408,652	408,409
Other non-current assets	71,173	94,674
Deferred taxes	208,494	201,860
Total assets	3,044,728	2,979,766
Current liabilities:
Accounts payable	19,727	20,925
Accrued liabilities	362,883	351,399
Income taxes payable	8,384	4,769
Contract liabilities	37,702	31,505
Operating lease liabilities	14,206	13,628
Total current liabilities	442,902	422,226
Non-current contract liabilities	36,453	39,997
Non-current operating lease liabilities	37,711	37,020
Other non-current liabilities	89,975	108,339
Total liabilities	607,041	607,582
Stockholders’ equity:
Retained earnings	2,449,876	2,391,990
Accumulated other comprehensive loss	(29,068)	(36,984)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,420,902	2,355,100
Noncontrolling interest	16,785	17,084
Total stockholders’ equity	2,437,687	2,372,184
Total liabilities and stockholders’ equity	3,044,728	2,979,766
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 59,737,770 shares issued and outstanding at March 29, 2024 and 59,673,633 at September 29, 2023
Stockholders’ equity:
Common stock	53	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,085,779 shares issued and outstanding at March 29, 2024 and 36,085,779 at September 29, 2023
Stockholders’ equity:
Common stock	$ 41	$ 41